BRSK2 Peptide Reference: GTX85053-PEP BRSK2 peptide is used for blocking the activity of BRSK2 antibody (catalog number GTX8553). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human EG-VEGF (Animal-Free) Reference: GFH7AF-5 Endocrine Gland-derived Vascular Endothelial Growth Factor (EG-VEGF) is an angiogenic growth factor that is expressed in the ovaries, testis, adrenal, and placental tissues. EG-VEGF has mitogenic, chemoattractive, and antiapoptotic functional roles. EG-VEGF signaling is mediated through binding the G protein-coupled receptors prokineticin receptor 1 (PKR1) and prokineticin receptor 2 (PKR2). Polycystic ovaries display strong EG-VEGF expression that is associated with increased angiogenesis and cyst formation, which could lead to the formation of polycystic ovary syndrome and infertility.
BRSK1 Peptide Reference: GTX85054-PEP BRSK1 peptide is used for blocking the activity of BRSK1 antibody (catalog number GTX8554). It usually blocks the antibody activity completely in Western blot by incubating with equal volume of antibody for 3 min at 37oC.
Recombinant Human EG-VEGF (Animal-Free) Reference: GFH7AF-20 Endocrine Gland-derived Vascular Endothelial Growth Factor (EG-VEGF) is an angiogenic growth factor that is expressed in the ovaries, testis, adrenal, and placental tissues. EG-VEGF has mitogenic, chemoattractive, and antiapoptotic functional roles. EG-VEGF signaling is mediated through binding the G protein-coupled receptors prokineticin receptor 1 (PKR1) and prokineticin receptor 2 (PKR2). Polycystic ovaries display strong EG-VEGF expression that is associated with increased angiogenesis and cyst formation, which could lead to the formation of polycystic ovary syndrome and infertility.
BRSK1 Peptide Reference: GTX85055-PEP BRSK1 peptide is used for blocking the activity of BRSK1 antibody (catalog number GTX8555). It usually blocks the antibody activity completely in Western blot by incubating with equal volume of antibody for 3 min at 37oC.
Recombinant Human EG-VEGF (Animal-Free) Reference: GFH7AF-100 Endocrine Gland-derived Vascular Endothelial Growth Factor (EG-VEGF) is an angiogenic growth factor that is expressed in the ovaries, testis, adrenal, and placental tissues. EG-VEGF has mitogenic, chemoattractive, and antiapoptotic functional roles. EG-VEGF signaling is mediated through binding the G protein-coupled receptors prokineticin receptor 1 (PKR1) and prokineticin receptor 2 (PKR2). Polycystic ovaries display strong EG-VEGF expression that is associated with increased angiogenesis and cyst formation, which could lead to the formation of polycystic ovary syndrome and infertility.
SCO1 Peptide Reference: GTX85056-PEP SCO1 peptide is used for blocking the activity of SCO1 antibody (catalog number GTX8556). It usually blocks the antibody activity completely in Western blot by incubating with equal volume of antibody for 3 min at 37oC.
Recombinant Human EG-VEGF (Animal-Free) Reference: GFH7AF-1000 Endocrine Gland-derived Vascular Endothelial Growth Factor (EG-VEGF) is an angiogenic growth factor that is expressed in the ovaries, testis, adrenal, and placental tissues. EG-VEGF has mitogenic, chemoattractive, and antiapoptotic functional roles. EG-VEGF signaling is mediated through binding the G protein-coupled receptors prokineticin receptor 1 (PKR1) and prokineticin receptor 2 (PKR2). Polycystic ovaries display strong EG-VEGF expression that is associated with increased angiogenesis and cyst formation, which could lead to the formation of polycystic ovary syndrome and infertility.
Orai1 Peptide Reference: GTX85057-PEP ORAI1 peptide is used for blocking the activity of Orai1 antibody (CatNo GTX8557). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human ENA-78 / CXCL5 Reference: GFH185-5 Epithelial-derived neutrophil-activating peptide 78 (ENA-78), also known as CXCL5, is a chemokine that recruits neutrophils, promotes angiogenesis, and stimulates connective tissue remodelling. ENA-78 production is stimulated by Interleukin-1 (IL-1) or tumor Necrosis Factor α (TNF-α), and signals through the chemokine receptor CXCR2. ENA-78 with 5 - 78 aminoacids is one of three naturally occuring ENA-78 variants in which the N-terminus has been truncated.
Emerin Peptide Reference: GTX85058-PEP Emerin peptide is used for blocking the activity of Emerin antibody (CatNo. GTX8558). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human ENA-78 / CXCL5 Reference: GFH185-20 Epithelial-derived neutrophil-activating peptide 78 (ENA-78), also known as CXCL5, is a chemokine that recruits neutrophils, promotes angiogenesis, and stimulates connective tissue remodelling. ENA-78 production is stimulated by Interleukin-1 (IL-1) or tumor Necrosis Factor α (TNF-α), and signals through the chemokine receptor CXCR2. ENA-78 with 5 - 78 aminoacids is one of three naturally occuring ENA-78 variants in which the N-terminus has been truncated.